On 17 September 2025, Alexion Pharmaceuticals Inc. announced a study is to evaluate the efficacy of ALXN2030 compared with placebo on biopsy proven histologic resolution in participants with active or ...

Ignoring albuminuria testing may lead to systematic underdiagnosis of chronic kidney disease, leaving millions of patients at unrecognized cardiovascular risk.

Renalytix plc (LSE: RENX) (OTCQB: RNLXY), today announced an agreement with Tempus AI, Inc. (NASDAQ: TEM) to make kidneyintelX.dkd prognostic blood testing more widely available for eligible patients ...

From a kidney donated by his father to a groundbreaking second transplant, BBC’s Stephen Watson shares his powerful story of resilience and advocacy.

Dementia warning signs can be detected by a simple urine test, according to new research. The study shows that people with higher levels of the protein albumin in their urine are at increased risk of ...

Neutrophil gelatinase-associated lipocalin (NGAL), a biomarker released in response to tubular injury, may serve as a noninvasive tool for measuring kidney injury. A new systematic review and ...

Chronic lead exposure can damage the kidneys, leading to long-term health problems that often go unnoticed until they become severe, according to the National Kidney Foundation (NKF).

CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) support the recent publication of the updated clinical practice guidelines for ...

A new study shows that people with higher levels of the protein albumin in their urine are at increased risk of developing dementia. The study, led by researchers at Karolinska Institutet, is ...

New preclinical data demonstrate deeper IgA reduction and a longer half-life compared to first-generation anti-APRIL monoclonal antibody CLYM116 Phase 1 trial initiation expected in Q4 2025, with ...

Anemia with renal tubular damage is an independent predictor of mortality in the general population. Anemia along with renal tubular damage (RTD) is associated with all-cause mortality in the general ...

FILSPARI® (sparsentan) suggested for IgA Nephropathy patients who are at risk of progressive kidney function loss ST. GALLEN, Switzerland, and SAN DIEGO, Sept. 26, 2025 /PRNewswire/ -- ...